Palisade Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.64

+0.14 (+9.33%)

As of Feb 8, 2:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +168.3% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $1.64

Current
$1.64

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

43.9%

Low target

Base Case

$4.40

+168.3%

Avg target

Bull Case

$4.89

+198.2%

High target

Risk/Reward

4.5x

Highly favorable

Price in Context

52-Week High

$3.92

-58.2% from high

52-Week Low

$2.47

+-33.6% from low

Target vs 52W High

$4.40

+12.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%